Technical Analysis for ORGS - Orgenesis Inc

Grade Last Price % Change Price Change
grade D 5.09 64.19% 1.9900
ORGS closed up 64.19 percent on Tuesday, January 21, 2020, on 3.92 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Up
Historical ORGS trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
200 DMA Support Bullish 64.19%
Hammer Candlestick Bullish 64.19%
Lizard Bullish Bullish Day Trade Setup 64.19%
Gilligan's Island Buy Setup Bullish Swing Setup 64.19%
Older signals for ORGS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Orgenesis Inc. is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company's subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced medicinal products. MaSTherCell is providing two types of services to its customers: process and assay development services and good manufacturing practice (GMP) contract manufacturing services. The CTB activity is based on its technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating (converting) them into pancreatic beta cell-like insulin producing cells for patients with Type I Diabetes. It intends to advance a product that combines cell-based therapy and regenerative medicine, Autologous Insulin Producing (AIP) cells, into clinical development.
Biotechnology RTT Branches Of Biology Diabetes Stem Cells Cell Therapy Regenerative Medicine Endocrine System Contract Manufacturing Services Hormones Peptide Hormones Insulin I Diabetes Medicinal Products Contract Development And Manufacturing Organization Diabetes Mellitus Type 1 Manufacturing Practice

Is ORGS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 10.75
52 Week Low 0.23
Average Volume 21,885
200-Day Moving Average 3.0266
50-Day Moving Average 7.4580
20-Day Moving Average 5.9255
10-Day Moving Average 4.6060
Average True Range 0.7269
ADX 33.1
+DI 32.4736
-DI 37.4247
Chandelier Exit (Long, 3 ATRs ) 7.6193
Chandelier Exit (Short, 3 ATRs ) 5.1607
Upper Bollinger Band 9.4815
Lower Bollinger Band 2.3695
Percent B (%b) 0.38
BandWidth 120.0236
MACD Line -0.9782
MACD Signal Line -0.8644
MACD Histogram -0.1138
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.6750
Resistance 3 (R3) 5.7100 5.5500 5.5775
Resistance 2 (R2) 5.5500 5.4010 5.5325 5.5450
Resistance 1 (R1) 5.3200 5.3090 5.2400 5.2850 5.5125
Pivot Point 5.1600 5.1600 5.1200 5.1425 5.1600
Support 1 (S1) 4.9300 5.0110 4.8500 4.8950 4.6675
Support 2 (S2) 4.7700 4.9190 4.7525 4.6350
Support 3 (S3) 4.5400 4.7700 4.6025
Support 4 (S4) 4.5050